Acelrx Pharmaceuticals reported $569K in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acelrx Pharmaceuticals ACRX:US USD 569K 307K
Baxter International BAX:US USD 2.63B 337M
Becton, Dickinson and BDX:US USD 2.68B 110M
Cara Therapeutics CARA:US USD 3.06M 3.06M
Heron Therapeutics HRTX:US USD 14.72M 1.46M
Intra Cellular Therapies ITCI:US USD 5.85M 1.2M
Johnson & Johnson JNJ:US USD 7.76B 29M
Pfizer PFE:US USD 9.82B 3.73B
Smiths SMIN:LN GBP 869M 133M
Teva Pharmaceutical TEVA:IT USD 1.88B 73M
Xeris Pharmaceuticals Inc XERS:US USD 5.26M 450K